Highly Efficient Biocompatible Lipid Nanoparticles for Biomedical Applications
Lipid nanoparticles have undergone significant advancements in biomedicine, evolving into a sophisticated platform for delivering therapeutic agents and imaging agents. Their biocompatibility, tuneable properties, and successful translation into clinical applications signify their maturity as a versatile and effective technology.
This technology is a patented lipid nanoparticle technology platform, designed to harness unique synergies from a combination of: (1) novel core fluorescence materials with tuneable wavelengths; (2) biocompatible lipid encapsulation matrix, delivering challenging materials in water-based environment; (3) surface functionalisation on nanoparticles, allowing for tailored targeting functionalities.
The technology is a key enabling solution for advanced fluorescence imaging and detection, with characteristics of high brightness, sensitivity, and biocompatibility. The high sensitivity and specificity of the technology allow researchers to obtain accurate and conclusive experimental data, whereas outstanding photostability eliminates concerns of signal loss, enabling precise visualization and long-term monitoring of cellular processes for both in-vitro and in-vivo studies.
The introduction of this technology opens new possibilities in accelerating biomedical breakthroughs, empowering studies in long-term in-vivo cell fate determination, drug development utilizing advanced 3D organoids, monitoring stem cell differentiation, transplantation, and potential for precision medicine and early diagnostic platforms, driving personalized therapeutic approaches, and leading to significant advancements in biomedicine and other similar applications.
The technology owner is seeking partners for research and application development projects, with the goal of integrating this technology into existing workflows and protocol for biotech companies and contract research organisations.